EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension

Shailina Keshwani iD, Kayla M Smith, Almut G Winterstein iD, Matthew J Gurka, Marta G Walsh, Anne Libby, William Hogan, Carl J Pepine, Rhonda M Cooper-DeHoff, Steven M Smith iD

American Journal of Hypertension · 2025

DOI: 10.1093/ajh/hpaf060 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Shailina Keshwani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Antihypertensive Agents, Blood Pressure, Healthcare Disparities, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Sex, race, and ethnicity disparities in hypertension (HTN) treatment intensity have been previously described. It remains unclear if these disparities occur at treatment onset and whether they can be explained by differences in clinical factors. METHODS We conducted a retrospective cross-sectional study of adults with newly treated HTN using linked EHR + claims data from OneFlorida + Consortium. We included Florida Medicaid & Medicare-recipients diagnosed with HTN and prescribed ≥ 1 first-line antihypertensive during 2013–2020. We used generalized linear models to estimate differences in total therapeutic intensity score (TTIS)–a patient’s total daily dose (TDD) divided by recommended maximum TDD for a drug, summed across entire regimen–by sex, race, and ethnicity. We then modeled the same, controlling for demographics, blood pressure, and relevant comorbidities. RESULTS In total 4,094 patients (mean age 58 ± 16; female 57.6%; White 56.7%) were included. We observed variations in the initiation of antihypertensive classes by sex, race and ethnicity. In univariate analyses, men averaged 7.6% (95% CI: 3.9%–11.3%) greater TTIS versus women and Black individuals averaged 10.5% (95% CI: 6.6%–14.3%) greater TTIS versus White individuals, whereas no disparities were observed by ethnicity. After adjusting for clinical factors, these disparities persisted: men had 7.6% (95% CI: 3.9%–11.4%) greater TTIS versus women, and Black individuals had 17.9% (95% CI: 13.8%–21.9%) greater TTIS versus White individuals. CONCLUSIONS We observed disparities in treatment intensity by sex and race that were not explained by differences in clinical factors. There was sex-based variation in practice patterns, and Black individuals received more intensive initial antihypertensive therapy than White individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsBlood PressureHealthcare DisparitiesHypertensionPractice Patterns, Physicians'AdultAgedFemaleHumansMaleMiddle AgedBlack or African AmericanCross-Sectional StudiesFloridaRace FactorsRetrospective StudiesSex FactorsUnited StatesWhite

Stichwörter der Autor:innen

EHR-linked claims datablood pressurehealth disparityhypertensionreal-world datatherapeutic intensity

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Department of Emergency Medicine, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
  • Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Shailina Keshwani, Almut G Winterstein, Steven M Smith

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Keshwani, S., Smith, K. M., Winterstein, A. G., Gurka, M. J., Walsh, M. G., Libby, A., Hogan, W., Pepine, C. J., Cooper-DeHoff, R. M., & Smith, S. M. (2025). Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf060

Vancouver

Keshwani S, Smith KM, Winterstein AG, Gurka MJ, Walsh MG, Libby A, et al. Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf060

BibTeX
@article{Keshwani2025,
  author = {Keshwani, Shailina and Smith, Kayla M and Winterstein, Almut G and Gurka, Matthew J and Walsh, Marta G and Libby, Anne and Hogan, William and Pepine, Carl J and Cooper-DeHoff, Rhonda M and Smith, Steven M},
  title = {Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension},
  journal = {American Journal of Hypertension},
  year = {2025},
  doi = {10.1093/ajh/hpaf060}
}
Kostenlos starten →